|
⚲
|
| Keyboard |
| Miller Steve
✚
|
|
|---|---|
| CIK # | 0001402535 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001402535] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Catalyst Pharmaceuticals Inc | |
| Miller Steve |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2025-12-29 | Option exercise | 14,000 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2025-12-29 | Option exercise | 14,000 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2025-12-08 | Option exercise | 11,873 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2025-12-08 | Option exercise | 11,873 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2025-11-21 | Option exercise | 8,267 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2025-11-21 | Option exercise | 8,267 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Options to purchase common stock · derivative
|
2025-11-20 | Grant | 158,454 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2025-11-20 | Grant | 47,826 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2025-02-14 | Option exercise | 13,667 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2025-02-14 | Option exercise | 13,667 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2024-12-27 | Option exercise | 14,000 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2024-12-27 | Option exercise | 14,000 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2024-12-13 | Option exercise | 235,000 | $4.01 | 942,350 |
|
Catalyst Pharmaceuticals Inc CPRX
Options to purchase common stock · derivative
|
2024-12-13 | Option exercise | 235,000 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2024-12-10 | Sell | 50,000 | $21.93 | 1,096,500 |
|
Catalyst Pharmaceuticals Inc CPRX
Options to purchase common stock · derivative
|
2024-12-10 | Option exercise | 50,000 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2024-12-10 | Option exercise | 50,000 | $4.01 | 200,500 |
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2024-12-09 | Option exercise | 11,872 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2024-12-09 | Option exercise | 11,872 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Options to purchase common stock · derivative
|
2024-11-21 | Grant | 202,958 | $0.00 | |
| showing 20 of 97 most recent transactions | |||||